Weight Loss Drugs Sold Online: Evaluating Safety of Alternatives to Ozempic and Wegovy
Weight Loss Drugs: Cheaper Yet Risky Alternatives
Weight loss drugs sold online, particularly compounded semaglutide, are gaining popularity as affordable options compared to popular medications like Ozempic and Wegovy.
Emerging Market for Compounded Drugs
The surge in online sales of these medications highlights a significant shift in patient behavior, focusing on accessibility and cost.
- Compounded semaglutide presents lower prices.
- Patients report improved access to treatment.
Health Experts’ Concerns
Despite the attractive pricing, health experts raise alarms regarding potential risks associated with these non-FDA-approved drugs.
- Possible side effects and lack of regulatory oversight.
- Shortages in quality control and inconsistency in dosage.
Implications for Patients
Patients considering these cheaper alternatives should weigh cost against safety. Consulting healthcare providers is essential in navigating these new options.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.